Archive

2016 - 2015 - 2014 - 2013 - 2011 - 2010 - 2009 - 2007 - All

10.07.2016	\|	JenaValve Technology Appoints Veteran Medical Device Executive Greg Mirigian as Vice President of Research and Development
01.07.2016	\|	JenaValve Technology Appoints Janet M. Fauls As Vice President Of Regulatory Affairs
11.11.2015	\|	JenaValve Announces Certification of New Transcatheter Heart Valve Manufacturing Facility
08.07.2015	\|	JenaValve receives $26.5million financing
08.04.2015	\|	JenaValve appoints Peter C. Wulff as Chief Financial Officer
06.02.2015	\|	JenaValve appoints Victoria E. Carr-Brendel, Ph.D., as Chief Executive Officer
08.12.2014	\|	JenaValve names Stefan Schreck, Ph.D. Chief Technology Officer
07.07.2014	\|	JenaValve names David J. Drachman Chief Executive Officer
04.07.2014	\|	JenaValve expands Series C Venture Financing Round
01.07.2014	\|	JenaValve names veteran sales and marketing executive Jeff Workman Chief Commercial Officer
06.04.2014	\|	JenaValve announces first implantation of transapical TAVI system in Sweden
01.07.2013	\|	JenaValve Technology Names Raymond W. Cohen as Executive Chairman of the Board
02.04.2013	\|	John Migliazza appointed as Chief Operating Officer
12.03.2013	\|	JenaValve Technology announces first implantation of its transapical TAVI system in Austria (German)
09.03.2013	\|	JenaValve Technology announces first implantation of its transapical TAVI system in Argentina
03.07.2011	\|	JenaValve Technology Names Dr. Katrin Leadley Chief Medical Officer (CMO)
04.01.2010	\|	JenaValve Closes € 19 Million Series B Financing Round
12.17.2013	\|	JenaValve Technology announces first implantations of its transapical TAVI system in France
12.23.2013	\|	JenaValve announces first implantation of transapical TAVI system in Poland
01.15.2015	\|	JenaValve appoints Jan Keltjens interim Chief Executive Officer
05.21.2014	\|	Primary endpoint data presented on performance and safety of the JenaValve Tavi System
08.19.2013	\|	JenaValve Technology announces first implantation of its transapical TAVI system in Canada
05.25.2010	\|	JenaValve Technology Reports Nine Successful Human Implantations of its Transapical TAVI System
04.28.2009	\|	JenaValve Names Michael J. Dormer as Chairman of the Board
09.21.2007	\|	JenaValve Closes 10 Million euro Series A-2 Financing Round
01.20.2016	\|	JenaValve Technology Appoints Pieter Van den Steen As Chief Commercial Officer, General Manager
01.30.2011	\|	JenaValve™ reports significant clinical milestone
09.30.2011	\|	CE certification
09.16.2013	\|	JenaValve Technology announces expanded CE mark approval for the treatment of aortic insufficiency
07.23.2013	\|	JenaValve Successfully Closes 62,5 million $ Series C Financing Round
05.22.2013	\|	JenaValve Technology Announce First Results of its Post-Market JUPITER Registry at EuroPCR 2013
01.22.2013	\|	Goldman Sachs Emerging Healthcare Series, JenaValve Technology: Differentiated TAVI system
10.15.2013	\|	FIERCEMEDICALDEVICES names JenaValve one of ‘Fierce 15’ top medical device and diagnostic companies of 2013

JenaValve, The JenaValve™, Cathlete™, JenaClip™ are trademarks of JenaValve Technology, Inc. Copyright © 2018 JenaValve Technology, Inc. All rights reserved.